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The Traditional Knowledge Digital Library
That, ladies and gentlemen, is how the Traditional
Knowledge Digital Library (1) came to be. As
Dr Bhatkar told you, that is why, if you put
‘Traditional Knowledge Digital Library’ into Google,
you are now one of 30 million plus hits. That is the
magnitude of the transformation that has taken place.
What we have done is to take Ayurvedic text, Sanskrit
text and converted them into English, codified them and
created a traditional knowledge resource classification.
This has then been linked to international patent
classification. Why is it important to have done so?
Because we discovered that, of the 10000 international
patent classification subgroups, only one was for tradi-
tional medicine. How can you have only one subgroup
out of 10000 for such a rich system? Now, thanks to our
Indian effort, there are 200 subgroups. I am sure, that as
other systems come in, that figure will become 2000.
I am very happy about the Traditional Knowledge
Digital Library. In June, the paper went to the cabinet,
which approved it in its entirety. They decided that it will
be CSIR who decides on access of the Traditional
Knowledge Digital Library to the International Patent
Offices. Now what will happen: there will be a connection
between the Sanskrit sloka in the Ayurvedic text and the
personal computer of the patent examiner in the US
patent office. Then, if he does ‘Turmeric’, ‘wound
healing’ and ‘powder’, he will not get a blank screen.
Instead, he will get all the knowledge in a language he
understands, because it has been codified and classified.
There would not be any wrong patents given.
Ayurveda as a World Medical System
As Prof. Bodeker and I were saying, this is the way
traditional knowledge systems have to penetrate. As he
has wisely and rightly pointed out, the same thing must
happen for the world’s medical regulatory systems. He is
absolutely right. Only with this kind of recognition will
we be able to fulfil our dream. My dream is not about
Ayurveda as one of a number of traditional medicine
systems; my dream is for Ayurveda to be recognized as a
universal medical system. It is entirely possible, but if we
do not set about these things, we will not be able to
achieve that dream. That is basically the point.
In my judgement, the Traditional Knowledge Digital
Library will serve as a bigger purpose that is part of this.
It will integrate widely scattered and distributed refer-
ences in traditional knowledge systems in retrievable
form. It will act as a bridge between traditional and
modern knowledge systems. Availability of that knowl-
edge in retrievable form in many languages will give
modern research a major impetus in both India and the
rest of the developing world, which will then also be able
to get involved in innovative research. So there is a huge
benefit to be had. It will raise the profile of Ayurveda so
that all doctors will recognize its value, the world over.
Science-based Ayurveda Products
Lastly, I want to mention two or three things that are
close to my heart. The first is that we now have an
opportunity to create new products, science-based,
Ayurvedic products, for which I see four different types
of use.
1. Those to be used for minor ailments like dysphagia,
unpleasant taste, anorexia, etc.
2. More specific products like detoxifiers, toners,
resistance builders and rejuvenators for longevity.
Both these sets of preparations are likely to be
available over-the-counter, OTC.
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may be administered together with allopathic prep-
arations. Traditional medicines may even partially
replace allopathic ones. These will most probably be
prescribed by existing medical practitioners who will
be using combo-therapy to take advantage of the
synergy between the two sets of preparations for
patients’ overall benefit. In combo-therapy, use will
be made of bio-enhancers, detoxifiers, toners and
specific therapeutic agents, such as those in group 2,
to accelerate recovery. Similar use may also be made
of them at hospitals based on existing systems. With
time, such combo-therapy may become acceptable
not only just in India, but also universally.
4. Treatment of diseases of old age for which these
systems have already shown a great degree of
efficacy: diseases of old age are of increasing
concern in the West, and include various forms of
cancer, AIDS, osteoporosis, arthritis, Alzheimer’s,
Parkinson’s disease and obesity and a whole range
of others. There are opportunities, opportunities and
opportunities.
Then there is detoxification. Although detoxification is
practiced in other traditional systems of medicine, to my
mind Ayurveda has the most elaborate procedures.
Mostly, mild detoxification procedures are practiced
through the digestive track and the skin. They can be
practiced even without a prescription for maintenance of
good health. If molecularly defined detoxifiers could be
generated, along with their mechanisms of action, this
mild therapy could become extremely popular with health
conscious people, not only just in India, but also
throughout the world. With the use of molecularly
defined and mechanistically understood products, there
arises the possibility of using plant extract fractions not
presently used for therapeutic purposes. Such new herbal
preparations could significantly increase the number of
available therapeutic preparations of herbal origin.
Questions of Toxicity and Mechanism
Now I want to talk about bhasmas. In addition to
molecularly defined, and mechanistically understood,
non-toxic herbal fractions containing only a few mole-
cules, there are other important preparations, which are
unique to Ayurveda: the bhasmas, which are made from
mixtures of metals or minerals. Most are traditionally
calcined in sealed earthen containers by burning cow
dung cakes, or else in furnaces. The final products are
fine powders about 50 microns, or less in diameter. They
use elements like lead, tin, iron, arsenic etc. Nearly 10%
of Ayurvedic products are bhasmas, I understand.
Most of the elements used in these preparations have
been classified in standard scientific textbooks as toxic.
For example, lead in any concentration is described as
toxic; not only that, it is known to accumulate in various
tissues. Bhasmas, however, are considered fast acting
healing agents and are used quite freely, particularly
Siddha preparations. No toxic effects have apparently
been reported from them; but to make them internation-
ally acceptable, it will not only be necessary to show that
they are efficacious and non-toxic, but also to define their
physicochemical characteristics by accurate scientific
measures. In this regard, you may find the work being
done at the National Chemical Laboratory by Dr Rajiv
Kumar of interest. He is looking at what is happening in
bhasmas at the atomic and molecular levels. Very, very
interesting findings are coming out (2).
My last question is: ‘How do we get scientists interested
in such research?’ Dr Kumar, for example, is busy
developing catalysts for Indian and international compa-
nies. How do I get scientists like him changing to looking
at bhasmas and such things, coming from that kind of
field? To my mind, that presents a big challenge. The first
need is to expose our best minds and our best scientists to
the accumulated wisdom of Indian systems of medicine,
including Ayurveda. We must do that, and this is a
terrific platform where it can happen. The way
Dr Bhatkar described the program, there are going to
be plenty of opportunities to do so. There is no doubt
that there are enormous opportunities for doing focussed,
basic-cum-applied research. Mechanisms need to be
elucidated in such areas as:
 actions of bhasmas
 detoxification
 reversal of ageing
 bio-enhancers and how molecular synergism occurs.
All these offer numbers of scientific challenges. All are
going to be very valuable.
Conclusion
I think what we need is not only just a meeting like this,
but also a meeting of minds. That is extremely important:
creating borderless minds is important, but at the same
time breaking borders is important. What is urgently
required are changes in attitude of scientists, traditional
practitioners and industry on one hand, and special
policy initiatives by the government on the other. Only
then will we be able to create that Golden Triangle.
Finally, I would like to reiterate some of the more
important points made by Valiathan (3). There is no
point in angry knee-jerk reactions, as, for example, when
somebody like Saper writes in the Journal of the
American Medical Association (4) about heavy metal
content of 70 samples of Ayurvedic herbal medicines and
the whole world reacts. Canada reacts and we jump
angrily. We should not be doing so. Nor, for example,
when the House of Lords in the UK classified Ayurveda
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papers on traditional medicine in New England Journal of
Medicine in 2002 (5–7), which did not refer to Ayurveda,
but did refer to everything else; and when our scientists
replied, their letter was not even accepted (8). We do not
have to react.
What we should do is put our own house in order (3).
How do we do that? First, encourage clinical research
in Ayurvedic institutions; second, create a complete
Ayurvedic pharmacopoeia of one or even two thousand
products, how many does not matter, but it must be
complete; third, create an effective surveillance system,
like the post-market surveillance systems for other
traditional systems, including support from modern
laboratories spread all over India; fourth, we must
carry out multi-centric trials of Ayurvedic biology; fifth,
we must establish a presence in international scientific
journals. There is no point in shouting; there is no point
in getting angry. We must have a very strong presence in
the world’s scientific journals, something eCAM has
already supported by nominating seven new Editorial
Board members from India (9).
We first built IIT’s i.e. Indian Institutes of Technology.
We already have IIM’s i.e. Indian Institutes of
Management. Then we built IIIT’s i.e. International
Institutes of Information Technology. We keep on
building them. What should we be building? We should
not worry about IIIT’s anymore. They are doing fine.
What we should worry about are IIIM’s. What is an
IIIM? An International Institute of Integrative Medicine:
that is where our great strength is. We should create and
demonstrate to the rest of the world our own power,
what it is, and where it lies.
I would like to end by thanking you once again for
giving me this opportunity to give this inaugural address.
I believe history is being created. The building housing
the Indian National Science Academy had never had
Ayurvedic practitioners enter its halls. I am well-known
for breaking such rules and traditions, so as President of
the Academy (one of the many hats I wear), I broke that
rule. Two years ago we had them all together, and
created a great dialogue with Rustum Roy and the many
others who came. I think there are new beginnings, and a
new hope for this great country of ours, India. Thank
you very much.
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